Kazuo Kasahara
Tokyo, 1138603, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications
Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 22, 2026
Right Ventricular Isovolumetric Relaxation Time is Associated with Pulmonary Vascular Load and Functional Limitation in Chronic Obstructive Pulmonary Disease.
Journal: International journal of chronic obstructive pulmonary disease
Published: June 02, 2026
Mepolizumab initiation by day 30 and glucocorticoid exposure in newly diagnosed EGPA: a single-center 30-day landmark cohort study.
Journal: BMC pulmonary medicine
Published: May 10, 2026
Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalities.
Journal: Respiratory investigation
Published: March 02, 2026
Methicillin-Resistant Staphylococcus aureus Septic Pulmonary Embolism Presumed to Originate From Anal Canal Cancer With a Cutaneous Fistula: A Case Report.
Journal: Cureus
Published: February 14, 2026
Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.
Journal: JTO clinical and research reports
Published: February 12, 2026
Simultaneous Diffuse Alveolar Hemorrhage and Acute Myocarditis in an Immunocompetent Adult with a Human Metapneumovirus Infection.
Journal: Internal medicine (Tokyo, Japan)
Published: December 24, 2025
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumonias.
Journal: Translational lung cancer research
Published: November 28, 2025
Low-dose vs standard-dose nintedanib at initiation in fibrosing interstitial lung disease: a target-trial emulation of treatment persistence and lung function.
Journal: Annals of the American Thoracic Society
Published: October 30, 2025
Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.
Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2025
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR-mutated NSCLC.
Journal: Future oncology (London, England)
Published: September 25, 2025
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysis.
Journal: Translational lung cancer research
Published: September 12, 2025
Last Updated: 09/26/2026